Cargando…

Minimizing bleeding risk in patients receiving direct oral anticoagulants for stroke prevention

Many primary care physicians are wary about using direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation (AF). Factors such as comorbidities, concomitant medications, and alcohol misuse increase concerns over bleeding risk, especially in elderly and frail patients with A...

Descripción completa

Detalles Bibliográficos
Autor principal:	Habert, Jeffrey Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066855/ https://www.ncbi.nlm.nih.gov/pubmed/27785089 http://dx.doi.org/10.2147/IJGM.S109104

Ejemplares similares

Evaluation of bleeding in patients receiving direct oral anticoagulants
por: Hellenbart, Erika L, et al.
Publicado: (2017)

Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants
por: ten Cate, Hugo, et al.
Publicado: (2017)

Management of bleeding in patients treated with direct oral anticoagulants
por: Levi, Marcel
Publicado: (2016)

Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
por: Cheung, Ka-Shing, et al.
Publicado: (2017)

Unmet Clinical Needs in Elderly Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation
por: Botto, Gianluca, et al.
Publicado: (2021)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Risks of postextraction bleeding after receiving direct oral anticoagulants or warfarin: a retrospective cohort study
por: Yagyuu, Takahiro, et al.
Publicado: (2017)

Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
por: Kim, Gwang-Un, et al.
Publicado: (2021)

Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk
por: Cid, Allison, et al.
Publicado: (2022)

Bleeding and thromboembolic risk in patients under anticoagulant therapy receiving oral surgery: a systematic review
por: Moldovan, Madalina A., et al.
Publicado: (2023)

Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

Bleeding complications from the direct oral anticoagulants
por: Sholzberg, Michelle, et al.
Publicado: (2015)

Direct Oral Anticoagulants for Stroke Prevention in Special Populations: Beyond the Clinical Trials
por: Carbone, Andreina, et al.
Publicado: (2023)

Acute Stroke Treatment in Patients Receiving Direct Oral Anticoagulants: Is it Time to Review the Guidelines?
por: Ojha, Pawan K., et al.
Publicado: (2023)

Reduction of major gastrointestinal bleeding risk with proton pump inhibitor therapy in patients with atrial fibrillation receiving direct oral anticoagulant
por: Lee, S R, et al.
Publicado: (2023)

Management of the Bleeding Patient Receiving New Oral Anticoagulants: A Role for Prothrombin Complex Concentrates
por: Baumann Kreuziger, Lisa M., et al.
Publicado: (2014)

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
por: Ment, Jerome
Publicado: (2015)

Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life
por: Zappulla, Paolo, et al.
Publicado: (2021)

Direct oral anticoagulants: patient reported adherence and minor bleedings
por: Hayat, Amina, et al.
Publicado: (2023)

Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities
por: Dobesh, Paul P., et al.
Publicado: (2015)

Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies
por: Bang, Oh Young, et al.
Publicado: (2023)

Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation
por: Raccah, Bruria Hirsh, et al.
Publicado: (2021)

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
por: Xu, Yunwen, et al.
Publicado: (2022)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants
por: Yoon, Ha-Young, et al.
Publicado: (2022)

Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
por: Ballestri, Stefano, et al.
Publicado: (2022)

Bleeding Risk in Nonvalvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies
por: Wang, Yimin Pearl, et al.
Publicado: (2020)

Re-bleeding and all-cause mortality risk in non-variceal upper gastrointestinal bleeding: focusing on patients receiving oral anticoagulant therapy
por: Kim, Won Shik, et al.
Publicado: (2023)

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications
por: Kefale, Adane Teshome, et al.
Publicado: (2023)

The incidence of atrial fibrillation, new oral anticoagulation, stroke, and significant bleeds in patients receiving a new dual-chamber pacemaker
por: Parkkari, Elias, et al.
Publicado: (2023)

Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
por: Dongre, Kanchan, et al.
Publicado: (2022)

Anticoagulant-related bleeding in patients receiving anticoagulant therapy over 10 years
por: Zhu, Lihong, et al.
Publicado: (2023)

Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants
por: Jhawar, Manish B, et al.
Publicado: (2012)

Assessment of delayed bleeding after endoscopic submucosal dissection of early-stage gastrointestinal tumors in patients receiving direct oral anticoagulants
por: Sugimoto, Mitsushige, et al.
Publicado: (2023)

Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants
por: Sarah, Lessire, et al.
Publicado: (2014)

Post-polypectomy bleeding and thromboembolism risks associated with warfarin vs direct oral anticoagulants
por: Yanagisawa, Naohiro, et al.
Publicado: (2018)

Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?
por: Lijfering, Willem M., et al.
Publicado: (2018)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
por: Song, Andrew B, et al.
Publicado: (2019)

The Prevention of Bleeding during Long-Term Oral Anticoagulant Therapy
por: Eastham, R. D.
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_9c2qpp0evttarqsi75k33h4qf5